Beyond Automation: How AI Transforms Clinical Evaluation Reports into Strategic Regulatory Assets
Some manufacturers are now embedding CER processes within broader regulatory operating systems, integrating authoring, surveillance, and quality management to enable real-time adaptability. Artificial Intelligence (AI) , in particular, is playing an increasingly critical role in helping manufacturers meet expanding regulatory expectations.
The post Beyond Automation: How AI Transforms Clinical Evaluation Reports into Strategic Regulatory Assets appeared first on MedTech Intelligence.